Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors Read More Sep 19, 2024
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering Read More Jul 23, 2024
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors Read More Jul 9, 2024
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives Read More May 9, 2024
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING Read More Mar 28, 2024
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction Read More Mar 6, 2024
